Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan

Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has spread globally very rapidly. The number of COVID-19 patients increased in Japan from late March to early April 2020. Since COVID-19 treatment methods with antivira...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Glob Health Med
Hlavní autoři: Saito, Sho, Hayakawa, Kayoko, Mikami, Ayako, Izumi, Shinyu, Funazaki, Hideki, Ashida, Shinobu, Sugiura, Wataru, Sugiyama, Haruhito, Kokudo, Norihiro, Ohmagari, Norio
Médium: Artigo
Jazyk:Inglês
Vydáno: National Center for Global Health and Medicine 2021
Témata:
Policy Forum
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071676/
https://ncbi.nlm.nih.gov/pubmed/33937567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.35772/ghm.2020.01106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky